2.76
+0.13(+4.94%)
Currency In USD
| Previous Close | 2.63 |
| Open | 2.71 |
| Day High | 2.83 |
| Day Low | 2.62 |
| 52-Week High | 6.08 |
| 52-Week Low | 2.47 |
| Volume | 1.18M |
| Average Volume | 813,981 |
| Market Cap | 228.63M |
| PE | -3.1 |
| EPS | -0.89 |
| Moving Average 50 Days | 4.27 |
| Moving Average 200 Days | 3.69 |
| Change | 0.13 |
If you invested $1000 in Codexis, Inc. (CDXS) 10 years ago, it would be worth $788.57 as of March 12, 2025 at a share price of $2.76. Whereas If you bought $1000 worth of Codexis, Inc. (CDXS) shares 5 years ago, it would be worth $305.31 as of March 12, 2025 at a share price of $2.76.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Codexis to Participate in TD Cowen 45th Annual Health Care Conference
GlobeNewswire Inc.
Feb 18, 2025 9:05 PM GMT
REDWOOD CITY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the TD Cowen 45th Annual
Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th
GlobeNewswire Inc.
Feb 13, 2025 9:05 PM GMT
REDWOOD CITY, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report its financial results for the
Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board
GlobeNewswire Inc.
Feb 06, 2025 9:05 PM GMT
REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Arthur Levin, PhD, to the Com